Houston Methodist opened a new tech hub in the Ion this week. Photo by Shannon O’Hara/Ion

Photos: Houston hospital opens tech hub in the Ion

innovation outpost

A Houston hospital has opened an innovation outpost in the Ion this week in order to showcase health tech innovation and connect with Houston innovators.

The Houston Methodist Tech Hub at Ion hub has officially opened. The 1,200-square-foot space was created in addition to the Center for Innovation Technology Hub that's in Houston Methodist’s flagship location in the Texas Medical Center, which opened in February 2020.

The new space, located on the lower level of the Ion, exists to serve as a common ground for innovators across industries to promote collisions and innovation, as well as interaction with Houston Methodist team members

“Our new Tech Hub at Ion supports not only our commitment to the Houston innovation community but also to the rapidly shifting healthcare industry,” Michelle Stansbury, vice president of innovation and IT applications at Houston Methodist, says in a statement. “We know we can’t solve the healthcare challenges of the future if we confine ourselves within our hospital walls or even within our own industry.

"We look forward to the collaborative space our new Tech Hub will provide and the future programming opportunities we can create together to inspire, challenge, and foster a spirit of innovation in our city.”

The new hub, according to the news release, also will host educational events, reverse pitch sessions, and more. Visitors can schedule a time to view the space or connect with the Houston Methodist innovation team by filling out a form online.

The hub, which was originally announced last year, is the latest partner to open within the Ion's space. Earlier this year, the organization announced other new tenants.

“Houston Methodist’s space at the Ion opens up even more opportunities for our start-up and entrepreneur community to embed and gain exposure to the latest innovations in health care, health technology, and digital health,” Jan E. Odegard, executive director of Ion, says. “This partnership and opportunity provided by Houston Methodist, a leading healthcare organization in the country, is a testament to the ecosystem we’re building and the talent within our building. Furthermore, Houston Methodist’s approach and appetite for cross-industry innovation and collaboration meshes seamlessly with the Ion’s ongoing plans to support Houston’s growing innovation community in industries and fields that will change the world.”

Both of Houston Methodist's tech hubs will showcase its latest technologies its implementing in its hospital system, including the "hospital of the future" it's building out in Cypress.

Collaborative effort

Photo by Shannon O’Hara/Ion

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston femtech co. debuts new lactation and wellness pods

mom pod

Houston-based femtech company Work&, previously known as Work&Mother, has introduced new products in recent months aimed at supporting working mothers and the overall health of all employees.

The company's new Lactation Pod and Hybrid Pod serve as dual-use lactation and wellness spaces to meet employer demand, the company shared in a news release. The compact pods offer flexible design options that can serve permanent offices and nearly all commercial spaces.

They feature a fully compliant lactation station while also offering wellness functionalities that can support meditation, mental health, telehealth and prayer. In line with Work&'s other spaces, the pods utilize the Work& scheduling platform, which prioritizes lactation bookings to help employers comply with the PUMP Act.

“This isn’t about perks,” Jules Lairson, Work& co-founder and COO, said in the release. “It’s about meeting people where they are—with dignity and intentional design. That includes the mother returning to work, the employee managing anxiety, and everyone in between.”

According to the company, several Fortune 500 companies are already using the pods, and Work& has plans to grow the products' reach.

Earlier this year, Work& introduced its first employee wellness space at MetroNational’s Memorial City Plazas, representing Work&'s shift to offer an array of holistic health and wellness solutions for landlords and tenants.

The company, founded in 2017 by Lairson and CEO Abbey Donnell, was initially focused on outfitting commercial buildings with lactation accommodations for working parents. While Work& still offers these services through its Work&Mother branch, the addition of its Work&Wellbeing arm allowed the company to also address the broader wellness needs of all employees.

The company rebranded as Work& earlier this year.

Rice biotech studio secures investment from Modi Ventures, adds founder to board

fresh funding

RBL LLC, which supports commercialization for ventures formed at the Rice University Biotech Launch Pad, has secured an investment from Houston-based Modi Ventures.

Additionally, RBL announced that it has named Sahir Ali, founder and general partner of Modi Ventures, to its board of directors.

Modi Ventures invests in biotech companies that are working to advance diagnostics, engineered therapeutics and AI-driven drug discovery. The firm has $134 million under management after closing an oversubscribed round this summer.

RBL launched in 2024 and is based out of Houston’s Texas Medical Center Helix Park. William McKeon, president and CEO of the TMC, previously called the launch of RBL a “critical step forward” for Houston’s life sciences ecosystem.

“RBL is dedicated to building companies focused on pioneering and intelligent bioelectronic therapeutics,” Ali said in a LinkedIn post. “This partnership strengthens the Houston biotech ecosystem and accelerates the transition of groundbreaking lab discoveries into impactful therapies.”

Ali will join board members like managing partner Paul Wotton, Rice bioengineering professor Omid Veiseh, scientist and partner at KdT Ventures Rima Chakrabarti, Rice alum John Jaggers, CEO of Arbor Biotechnologies Devyn Smith, and veteran executive in the life sciences sector James Watson.

Ali has led transformative work and built companies across AI, cloud computing and precision medicine. Ali also serves on the board of directors of the Drug Information Association, which helps to collaborate in drug, device and diagnostics developments.

“This investment by Modi Ventures will be instrumental to RBL’s growth as it reinforces confidence in our venture creation model and accelerates our ability to develop successful biotech startups,” Wotton said in the announcement. "Sahir’s addition to the board will also amplify this collaboration with Modi. His strategic counsel and deep understanding of field-defining technologies will be invaluable as we continue to grow and deliver on our mission.”